LATEST PRESS RELEASES
FEBRUARY 29, 2024
IRLAB to present at Life Science-dagen in Gothenburg and have a fireside chat with ABG
Gothenburg, Sweden, February 29, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will present at the event Life Science-dagen in Gothenburg on March 6. The company will also participate in a fireside chat with ABG, to be published on March 6.
Read More >
FEBRUARY 28, 2024
IRLAB to present at the Bayes@Lund 2024 Conference in Lund, Sweden on March 7
Read More >
FEBRUARY 27, 2024
IRLAB to present clinical and preclinical data at the AD/PD™ 2024: 18th International Conference on Alzheimer’s & Parkinson’s Diseases
Read More >
EVENT CALENDAR
FINANCIAL CALENDAR
NEXT
week 18 (April 29-May 3)
Annual report
FOLLOWING
May 8, 2024
Interim report January-March 2024